Skip to content
- Pharmacy
- April 27, 2023
- 1 min read
Heart Failure Among Patients with Multiple Myeloma Treated with Carfilzomib-Based Versus Non-Carfilzomib-Based Regimens in the United States by Race
- Shuling Li , Brandon T Suehs , Alan Fu , Laura Sangaré , Chris Kim , Victor M Gastanaga, Jiannong Liu, Heng Yan, Yihua Xu, Joseph Mikhael
Read More
- Pharmacy
- July 8, 2021
- 2 min read
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study
- Veena Hoffman; Jesper Hallas; Marie Linder; Andrea V Margulis; Brandon T Suehs; Alejandro Arana; Kelesitse Phiri; Cheryl Enger; Libby Horter; Ingvild Odsbu; Morten Olesen; Susana Perez-Gutthann; Yihua Xu; Nina Sahlertz Kristiansen; Kwame Appenteng; Stefan de Vogel; John D Seeger; mirabegron PMR-PASS study group
Read More
- Pharmacy
- April 9, 2021
- 1 min read
A Real-World Comparison of Cardiovascular, Medical and Costs Outcomes in New Users of SGLT2 Inhibitors versus GLP-1 Agonists
- Insiya B Poonawalla; Andy T Bowe; Michael C Tindal; Yunus A Meah; Phil Schwab
Read More